BLZ945
Important Notice: For research use only. We do not sell to patients.
Loading distributor info...
Important Notice: For research use only. We do not sell to patients.
Loading distributor info...
Discription | BLZ945 is a potent and selective CSF-1R kinase inhibitor. It attenuates the turnover rate of TAMs while increasing the number of CD8+ T cells that infiltrate cervical and breast carcinomas. | ||
---|---|---|---|
Targets |
|
Catalog Num | A15540 |
---|---|
Formula | C20H22N4O3S |
Molecular Weight | 398.4 |
CAS Number | 953769-46-5 |
SMILES | CNC(=O)C1=NC=CC(=C1)OC2=CC3=C(C=C2)N=C(S3)NC4CCCCC4O |
Synonyms | BLZ 945, BLZ-945 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 77 mg/mL (193.23 mM) | |
Water | Insoluble | ||
Ethanol | Warmed: 3 mg/mL | ||
In vivo | 4% DMSO+30% PEG 300+ddH2O | 2.3 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 25.1 mL | 125.5 mL | 251 mL |
0.5 mM | 5.02 mL | 25.1 mL | 50.2 mL |
1 mM | 2.51 mL | 12.55 mL | 25.1 mL |
5 mM | 0.5 mL | 2.51 mL | 5.02 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2